Boule Diagnostics AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0011231158
SEK
5.92
-1.92 (-24.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Boule Diagnostics AB stock-summary
stock-summary
Boule Diagnostics AB
Pharmaceuticals & Biotechnology
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Company Coordinates stock-summary
Company Details
Domnarsvgatan 4 , SPANGA None : 163 53
stock-summary
Tel: 46 8 7447700
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Peter von Ehrenheim
Independent Chairman of the Board
Mr. Thomas Eklund
Director
Ms. Charlotta Falvin
Director
Ms. Karin Dahllof
Independent Director
Mr. Jon Risfelt
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
129 Million
(Quarterly Results - Jun 2025)
Net Profit:
-6 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 224 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.10

stock-summary
Return on Equity

-40.18%

stock-summary
Price to Book

1.33